These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection. Deguit CDT; Hough M; Hoh R; Krone M; Pilcher CD; Martin JN; Deeks SG; McCune JM; Hunt PW; Rutishauser RL J Acquir Immune Defic Syndr; 2019 Oct; 82(2):211-219. PubMed ID: 31513075 [TBL] [Abstract][Full Text] [Related]
8. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Wang S; Zhang Q; Hui H; Agrawal K; Karris MAY; Rana TM Emerg Microbes Infect; 2020 Dec; 9(1):2333-2347. PubMed ID: 32954948 [TBL] [Abstract][Full Text] [Related]
9. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. Chew GM; Fujita T; Webb GM; Burwitz BJ; Wu HL; Reed JS; Hammond KB; Clayton KL; Ishii N; Abdel-Mohsen M; Liegler T; Mitchell BI; Hecht FM; Ostrowski M; Shikuma CM; Hansen SG; Maurer M; Korman AJ; Deeks SG; Sacha JB; Ndhlovu LC PLoS Pathog; 2016 Jan; 12(1):e1005349. PubMed ID: 26741490 [TBL] [Abstract][Full Text] [Related]
10. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8 Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771 [TBL] [Abstract][Full Text] [Related]
11. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses. Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532 [TBL] [Abstract][Full Text] [Related]
12. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. Pombo C; Wherry EJ; Gostick E; Price DA; Betts MR J Infect Dis; 2015 Nov; 212(9):1376-86. PubMed ID: 25883386 [TBL] [Abstract][Full Text] [Related]
13. Reversal of the CD8 Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C Front Immunol; 2021; 12():687296. PubMed ID: 34177939 [TBL] [Abstract][Full Text] [Related]
14. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B. Montali I; Ceccatelli Berti C; Morselli M; Acerbi G; Barili V; Pedrazzi G; Montanini B; Boni C; Alfieri A; Pesci M; Loglio A; Degasperi E; Borghi M; Perbellini R; Penna A; Laccabue D; Rossi M; Vecchi A; Tiezzi C; Reverberi V; Boarini C; Abbati G; Massari M; Lampertico P; Missale G; Ferrari C; Fisicaro P J Hepatol; 2023 Jul; 79(1):50-60. PubMed ID: 36893853 [TBL] [Abstract][Full Text] [Related]
15. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells. Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913 [TBL] [Abstract][Full Text] [Related]
16. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy. Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052 [TBL] [Abstract][Full Text] [Related]
17. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells. Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM mBio; 2021 Feb; 12(1):. PubMed ID: 33531395 [TBL] [Abstract][Full Text] [Related]
18. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. Poonia B; Pauza CD PLoS One; 2014; 9(2):e88884. PubMed ID: 24520422 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV. Calvet-Mirabent M; Sánchez-Cerrillo I; Martín-Cófreces N; Martínez-Fleta P; de la Fuente H; Tsukalov I; Delgado-Arévalo C; Calzada MJ; de Los Santos I; Sanz J; García-Fraile L; Sánchez-Madrid F; Alfranca A; Muñoz-Fernández MÁ; Buzón MJ; Martín-Gayo E EBioMedicine; 2022 Jul; 81():104090. PubMed ID: 35665682 [TBL] [Abstract][Full Text] [Related]
20. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. Sakhdari A; Mujib S; Vali B; Yue FY; MacParland S; Clayton K; Jones RB; Liu J; Lee EY; Benko E; Kovacs C; Gommerman J; Kaul R; Ostrowski MA PLoS One; 2012; 7(7):e40146. PubMed ID: 22792231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]